Novel octapeptin antibiotics targeting extremely drug resistant 'superbugs'
Novel octapeptin antibiotics targeting extremely drug resistant 'superbugs'
新型八肽抗生素针对耐药性极强的“超级细菌”
批准号：
nhmrc : GNT1128891
负责人：
A/Pr Tony Velkov
金额：
$94.6万
依托单位国家：
澳大利亚
项目类别：
Project Grants
财政年份：
2017
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2017-01-01 至 --
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The World Health Organization (WHO) has identified antimicrobial resistance as one of the three greatest threats to human health. Many clinicians worldwide have already been confronted with the reality of infections caused by extremely drug resistant (XDR) bacterial 'superbugs' resistant to all available antibiotics. This project aims to develop safe and efficacious octapeptin antibiotics for the treatment of life-threatening infections caused by problematic XDR ‘superbugs'.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrative systems pharmacology, neutron reflectometry and molecular dynamics approaches to unravelling the interactions between polymyxins and bacterial membranes
-
批准号：nhmrc : GNT1144652
-
项目类别：Project Grants
-
资助金额：$96.8万
-
财政年份：2018
-
负责人：A/Pr Tony Velkov
-
依托单位：
Optimising inhaled polymyxins as a vital therapy for pulmonary infections: A novel biochemical, molecular imaging and systems pharmacology approach
-
批准号：nhmrc : GNT1104581
-
项目类别：Project Grants
-
资助金额：$72.8万
-
财政年份：2016
-
负责人：A/Pr Tony Velkov
-
依托单位：
The Hunt for New-generation Lipopeptide Antibiotics Targeting Gram-negative ‘Superbugs’
-
批准号：nhmrc : GNT1086825
-
项目类别：Career Development Fellowships
-
资助金额：$45.55万
-
财政年份：2015
-
负责人：A/Pr Tony Velkov
-
依托单位：
海外基金